HCV protease inhibitor Tegobuvir, Purity ≥98%

Cat. No.: X24-06-ZQ944

HCV protease inhibitor Tegobuvir, Purity ≥98%

Synonym: 1000787-75-6; HCV protease inhibitor; GS9190; GS 333126; GS 9190; GS-333126; GS333126

  • MDL: MFCD18251457
  • CAS Number: 1000787-75-6
  • Compound CID: 23649154
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
Tegobuvir, soluble in DMSO and ethanol and insoluble in water, targets and inhibits the function of the hepatitis C virus protease enzyme.
Molecular Weight
517.41
Molecular Formula
C25H14F7N5
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 89 mg/mL (172.01 mM); Water: Insoluble; Ethanol: 89 mg/mL
Identity
Confirmed by NMR/HPLC/MS.
Applications
Tegobuvir acts as an HCV protease inhibitor, impeding the replication of the hepatitis C virus.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0